Hemophagocytic Lymphohistiocytosis and Miliary Tuberculosis in an Apparently Immunocompetent Patient: A Case Report.
Filippo DucciFrancesca MariottiJessica MencariniClaudio FabbriAlessandra Francesca ManuntaDaniela MesseriPaola ParronchiPierluigi BlancAlessandro BartoloniPublished in: Infectious disease reports (2024)
Hemophagocytic lymphohistiocytosis (HLH) is a serious haematologic condition that can be related to various diseases, including tuberculosis (TB). The patient is a previously healthy 26-year-old man, originally from western Africa, admitted to hospital for fever and weight loss. Given the results of a computed tomography (CT) scan, ocular examination and microbiologic tests, miliary TB with pulmonary, lymph nodal and ocular involvement was diagnosed. Following the introduction of antitubercular treatment (ATT), an increase in inflammation indexes and severe pancytopenia were observed; at this point, the patient presented with six of the eight diagnostic criteria for HLH, and a diagnosis of HLH secondary to TB was raised. Therefore, HLH treatment with a high dose of dexamethasone was started, with a good clinical response. We performed a literature review of TB-related HLH, which shows a high mortality rate. ATT is necessary to ensure patient survival to remove the antigenic driver. Our patient developed HLH after the initiation of ATT as a paradoxical reaction, which may be linked to the release of antigens due to the bactericidal effect of ATT.
Keyphrases
- case report
- mycobacterium tuberculosis
- computed tomography
- high dose
- weight loss
- healthcare
- low dose
- oxidative stress
- bariatric surgery
- squamous cell carcinoma
- lymph node
- risk factors
- dendritic cells
- type diabetes
- pulmonary hypertension
- dual energy
- body mass index
- radiation therapy
- stem cell transplantation
- combination therapy
- obese patients
- optic nerve
- pet ct
- electronic health record